Judge Refuses Remand Of California Suit Over Insulin Pricing

( June 12, 2025, 8:11 AM EDT) -- CAMDEN, N.J. — A New Jersey federal judge overseeing multidistrict litigation over the pricing of insulin denied the state of California’s renewed motion to remand its claims against pharmacy benefit managers (PBMs) for violating California’s unfair competition law (UCL) by unfairly setting insulin prices, finding that removal to federal court was proper despite the state’s disclaimers releasing any interest in recovery under federal law....